Charles B. Wilson MD, DSc, MSHA
As Chairman of Neurological Surgery at UCSF for 28 years, founding director of the Brain Tumor Research Center (BTRC), and the first professor to hold the Tong-Po Kan Chair of Neurological Surgery at UCSF, Dr. Wilson developed UCSF's integrally related, translational program of basic science and clinical research into the biology and therapy of brain tumors. By 1970, he had established the Department of Neurological Surgery and Brain Tumor Research Center (BTRC), a national cancer research center, which has been continuously funded by the National Institutes of Health since 1972. As Director of the BTRC, Dr. Wilson realized an integrally related program of basic science and clinical research. The BTRC treats over 500 brain tumor patients each year, contributes extensively to basic and applied research in neuro-oncology, trains numerous neuro-oncologists and clinical and basic scientists in brain tumor research, and provides continuing education and consultation for private practitioners
He has served on the National Cancer Advisory Board of the National Cancer Institute and is a senior member of the Institute of Medicine. Having a particular clinical interest in pituitary disorders, he has performed over 3300 operations for the removal of pituitary adenomas and has contributed to the neurosurgical literature extensive evaluations of his series of patients treated for such adenomas. Recently, he was awarded the 'Gentle Giant Award' by the Pituitary Network Association (PNA), recognizing his dedication and contributions to pituitary and endocrinologic medicine.
Addressing severe changes in the health care delivery system during the 1990s, Dr. Wilson served as Senior Associate on Medical Affairs to the President of the University of California, in addition to his clinical practice at UCSF. In 1996 he obtained a Masters degree in Health Administration. Dr. Wilson is a Director at the Institute for the Future, a forecasting organization located in Menlo Park and San Francisco, which he joined in 1997. His areas of expertise are emerging medical technologies, academic medical centers, the health care workforce, and the impact of genomic medicine on health and health care.